Molecular perturbations restrict potential for liver repopulation of hepatocytes isolated from non–heart-beating donor rats

Authors

  • Yuta Enami,

    1. Marion Bessin Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY
    2. Department of Surgery, Division of General and Gastroenterological Surgery, School of Medicine, Showa University, Shinagawa-ku, Tokyo, Japan
    Search for more papers by this author
  • Brigid Joseph,

    1. Marion Bessin Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY
    Search for more papers by this author
  • Sriram Bandi,

    1. Marion Bessin Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY
    Search for more papers by this author
  • Juan Lin,

    1. Department of Epidemiology & Population Health,Albert Einstein College of Medicine, Bronx, NY
    Search for more papers by this author
  • Sanjeev Gupta

    Corresponding author
    1. Marion Bessin Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY
    2. Department of Pathology,Albert Einstein College of Medicine, Bronx, NY
    3. Cancer Research Center,Albert Einstein College of Medicine, Bronx, NY
    4. Diabetes Research Center,Albert Einstein College of Medicine, Bronx, NY
    5. Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research,Albert Einstein College of Medicine, Bronx, NY
    6. Institute for Clinical and Translational Research, Albert Einstein College of Medicine, Bronx, NY
    • Albert Einstein College of Medicine, Ullmann Bldg., Rm 625, 1300 Morris Park Avenue, Bronx, NY 10461===

    Search for more papers by this author
    • fax: 718-430-8975


  • Potential conflict of interest: Nothing to report.

  • Supported by National Institutes of Health grants R01 DK071111, R01 DK088561, P30 DK41296, and P30 CA13330.

Abstract

Organs from non–heart-beating donors are attractive for use in cell therapy. Understanding the nature of molecular perturbations following reperfusion/reoxygenation will be highly significant for non–heart-beating donor cells. We studied non–heart-beating donor rats for global gene expression with Affymetrix microarrays, hepatic tissue integrity, viability of isolated hepatocytes, and engraftment and proliferation of transplanted cells in dipeptidyl peptidase IV-deficient rats. In non–heart-beating donors, liver tissue was morphologically intact for >24 hours with differential expression of 1, 95, or 372 genes, 4, 16, or 34 hours after death, respectively, compared with heart-beating donors. These differentially expressed genes constituted prominent groupings in ontological pathways of oxidative phosphorylation, adherence junctions, glycolysis/gluconeogenesis, and other discrete pathways. We successfully isolated viable hepatocytes from non–heart-beating donors, especially up to 4 hours after death, although the hepatocyte yield and viability were inferior to those of hepatocytes from heart-beating donors (P < 0.05). Similarly, although hepatocytes from non–heart-beating donors engrafted and proliferated after transplantation in recipient animals, this was inferior to hepatocytes from heart-beating donors (P < 0.05). Gene expression profiling in hepatocytes isolated from non–heart-beating donors showed far greater perturbations compared with corresponding liver tissue, including representation of pathways in focal adhesion, actin cytoskeleton, extracellular matrix–receptor interactions, multiple ligand–receptor interactions, and signaling in insulin, calcium, wnt, Jak-Stat, or other cascades. Conclusion: Liver tissue remained intact over prolonged periods after death in non–heart-beating donors, but extensive molecular perturbations following reperfusion/reoxygenation impaired the viability of isolated hepatocytes from these donors. Insights into molecular changes in hepatocytes from non–heart-beating donors offer opportunities for improving donor cell viability, which will advance the utility of non–heart-beating donor organs for cell therapy or other applications. (HEPATOLOGY 2012)

Ancillary